scPharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	162	225	197	137	145	105	70	213
Market Cap Growth	-	14.31%	43.24%	-4.98%	37.04%	51.05%	-67.21%	-
Enterprise Value	126	189	116	79	59	53	-8	106
PE Ratio	-4.10	-4.10	-5.34	-4.90	-4.49	-3.20	-2.37	-8.94
PS Ratio	11.91	16.54	-	-	-	-	-	-
PB Ratio	4.35	6.04	2.72	2.43	1.76	2.05	0.89	2.01
P/FCF Ratio	-3.79	-3.79	-5.69	-5.06	-5.22	-3.46	-2.42	-9.31
P/OCF Ratio	-3.80	-3.80	-5.69	-5.06	-5.22	-3.46	-2.42	-9.39
EV/Sales Ratio	9.28	13.91	-	-	-	-	-	-
EV/EBITDA Ratio	-4.11	-4.11	-3.50	-3.18	-2.03	-1.71	0.31	-4.60
EV/EBIT Ratio	-4.05	-4.05	-3.45	-3.12	-2.01	-1.69	0.30	-4.59
EV/FCF Ratio	-3.19	-3.19	-3.34	-2.93	-2.15	-1.74	0.29	-4.62
Debt / Equity Ratio	1.08	1.08	0.52	0.31	0.25	0.39	0.14	0.11
Debt / EBITDA Ratio	-0.87	-0.87	-1.13	-0.70	-0.69	-0.66	-0.41	-0.49
Debt / FCF Ratio	-0.68	-0.68	-1.08	-0.65	-0.73	-0.67	-0.39	-0.50
Quick Ratio	6.13	6.13	15.96	5.08	11.29	13.90	13.44	22.74
Current Ratio	7.08	7.08	16.63	5.27	11.57	14.45	13.77	23.01
Asset Turnover	0.12	0.12	0	0	0	0	0	0
Interest Coverage	-5.75	-5.75	-10.16	-9.89	-11.45	-17.67	-19.56	-28.88
Return on Equity (ROE)	-97.20%	-97.20%	-76.20%	-42.50%	-39.60%	-54.30%	-33.80%	-69.10%
Return on Assets (ROA)	-49.60%	-49.60%	-49.00%	-31.10%	-29.90%	-39.40%	-28.60%	-29.40%
Return on Capital (ROIC)	-71.49%	-71.49%	-32.93%	-34.85%	-29.24%	-45.94%	-32.93%	-19.97%
Earnings Yield	-33.86%	-24.38%	-18.73%	-20.41%	-22.29%	-31.29%	-42.17%	-11.19%
FCF Yield	-36.62%	-26.37%	-17.59%	-19.78%	-19.16%	-28.86%	-41.27%	-10.74%
Buyback Yield / Dilution	-35.81%	-35.81%	-3.68%	-11.33%	-32.09%	-0.24%	-526.29%	-203.99%
Total Shareholder Return	-35.81%	-35.81%	-3.68%	-11.33%	-32.09%	-0.24%	-526.29%	-203.99%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).